We constantly update this page with the news and events to keep you posted as to what steps we have taken to better serve our clients.

EASY GLOBAL TRAINING Renewed the Agreement to Provide Medical Affairs Consulting Services for sBLA Filing of KEYTRUDA® (pembrolizumab) with FDA.

Mon. 2 Jan 2017

As of Jan 1, 2017, Easy Global Training renewed its agreement with Merck, a leading global biopharmaceutical company, for regulatory writing process of accelerated sBLA filing of Keytruda® (Pembolizumab) oncology drug, a breakthrough organ agnostic cancer treatment drug, with FDA. KEYTRUDA® (pembrolizumab) is a prescription medication that is used to treat Advanced Melanoma, Non-Small Cell Lung […]

Easy Global Training Entered an Agreement with Johnson & Johnson to Support Their Clinical Evaluation Review Updates to Become Compliant with MEDDEV 2.7.1 Rev 4

Mon. 22 Aug 2016

As of Aug 22, 2016, Easy Global Training entered an agreement with Johnson & Johnson to Support Their Clinical Evaluation Review Updates for their Orthopedics devices to become compliant with MEDDEV 2.7.1 Rev 4 for European Union market authorization. The MOUNTAINEER Laminoplasty System is an implant system that consists of screws and various sizes of […]

Dr. Afsaneh Motamed Khorasani Was Invited to Speak on “The Utility of DR-70, a Novel Blood Biomarker, in the Early Detection of Many Types of Cancers.”

Sun. 27 Mar 2016

The 14th Asian Symposium on Hepatology and Laboratory Medicine (ASCPaLM 2016) was held in March 2016. A large number of domestic and foreign physicians and experts and scholars were present at the conference. Invited speaker from United States:  Afsaneh (Eva) Motamed Khorasani, PhD                           […]